Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 26

1.

Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder.

Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N.

J Womens Health Gend Based Med. 2002 May;11(4):367-77.

PMID:
12150499
2.

Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.

Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ.

Arch Intern Med. 2002 Jun 24;162(12):1349-60. Review.

PMID:
12076233
3.

Sildenafil citrate for female sexual arousal disorder: a future possibility?

Schoen C, Bachmann G.

Nat Rev Urol. 2009 Apr;6(4):216-22. doi: 10.1038/nrurol.2009.25. Review.

PMID:
19352396
4.

[Sex, erectile dysfunction, and the heart: a growing problem].

Görge G, Flüchter S, Kirstein M, Kunz T.

Herz. 2003 Jun;28(4):284-90. Review. German.

PMID:
12825143
5.

Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis.

Xiao Y, Wang J, Luo H.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD009427. doi: 10.1002/14651858.CD009427.pub2. Review.

PMID:
22513975
6.

Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction.

Goldenberg MM.

Clin Ther. 1998 Nov-Dec;20(6):1033-48. Review.

PMID:
9916601
8.

Clinical update on sildenafil citrate.

Osterloh IH, Riley A.

Br J Clin Pharmacol. 2002 Mar;53(3):219-23. Review. No abstract available.

9.

Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.

Laties A, Sharlip I.

J Sex Med. 2006 Jan;3(1):12-27. Review.

PMID:
16409214
10.

Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?

Chivers ML, Rosen RC.

J Sex Med. 2010 Feb;7(2 Pt 2):858-72. doi: 10.1111/j.1743-6109.2009.01599.x. Epub 2009 Nov 19. Review.

PMID:
19929916
11.

Cardiovascular safety of sildenafil.

Tran D, Howes LG.

Drug Saf. 2003;26(7):453-60. Review.

PMID:
12735784
12.
13.

Sexual dysfunction and depression.

Seidman SN, Roose SP.

Curr Psychiatry Rep. 2001 Jun;3(3):202-8. Review.

PMID:
11353583
14.

Systematic review and meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female sexual dysfunction.

Gao L, Yang L, Qian S, Li T, Han P, Yuan J.

Int J Gynaecol Obstet. 2016 May;133(2):139-45. doi: 10.1016/j.ijgo.2015.08.015. Epub 2015 Dec 17. Review.

PMID:
26797204
15.

The impact of the new sexual pharmaceuticals on sex therapy.

Perelman MA.

Curr Psychiatry Rep. 2001 Jun;3(3):195-201. Review.

PMID:
11353582
16.

Neurologic, psychological, and aggressive disturbances with sildenafil.

Milman HA, Arnold SB.

Ann Pharmacother. 2002 Jul-Aug;36(7-8):1129-34. Review.

PMID:
12086542
17.

Cardiovascular safety of sildenafil.

Kell P.

Int J STD AIDS. 2002 Jul;13(7):439-43. Review. No abstract available.

PMID:
12171661
18.

Sildenafil-associated hepatoxicity: a review of the literature.

Graziano S, Montana A, Zaami S, Rotolo MC, Minutillo A, Busardò FP, Marinelli E.

Eur Rev Med Pharmacol Sci. 2017 Mar;21(1 Suppl):17-22. Review.

19.

Sexual aspects of headache. How sexual function relates to headaches and their causes and treatment.

Goldstein J.

Postgrad Med. 2001 Jan;109(1):81-4, 87-8, 92. Review.

PMID:
11198260
20.

Phosphodiesterase inhibitors in female sexual dysfunction.

Mayer M, Stief CG, Truss MC, Uckert S.

World J Urol. 2005 Dec;23(6):393-7. Epub 2005 Oct 25. Review.

PMID:
16247643

Supplemental Content

Support Center